| David A. Gass works tirelessly with biotechnology companies and institutions to develop and implement strategies for maximizing the value of their innovations. He has extensive experience prosecuting patent applications internationally in numerous molecular biology, immunology, diagnostic, therapeutic, and related disciplines. He also counsels clients on all aspects of intellectual property, helping them develop business strategies and manage the patent life cycle for products, negotiating license agreements, plus assessing freedom to operate relative to others' intellectual property rights. Mr. Gass has also successfully handled interference proceedings before the U.S. Patent and Trademark Office and advised counsel worldwide in foreign patent prosecution and opposition proceedings. Recent Client Work: Counseled research institution and prosecuted portfolio of patent applications relating to angiogenic treatments for ischemic conditions and anti-angiogenic treatments for cancer. Continued prosecution of portfolio for a startup company built around these technologies. Secured more than 20 U.S. patents and numerous foreign counterpart patents for prominent platform technology for large pharmaceutical company. Assisted with U.S. interference and subsequent prosecution of patent application for important plant biotechnology invention. Provided freedom to operate counseling to clients that wished to develop a product without infringing valid intellectual property rights of third parties.
Counseled clients in U.S. interferences and assisted foreign counsel in European and Australian opposition proceedings. Representative Experience: Mr. Gass has handled matters in a wide variety of biotechnology disciplines, such as: Recombinant DNA, protein, and antibody technologies;
Genomics and proteomics;
Medical diagnostics and kits that involve genomic, metabolomic, and traditional methodologies and markers for predicting disease;
Angiogenesis and anti-angiogenesis technologies and circulatory disorders;
Gene therapy, interfering RNA, and antisense technologies;
Genetic engineering of plants and animals;
Recombinant growth factors, enzymes, chemokines, and cell surface receptors;
Cancer and oncogenes;
Anti-viral therapies and research tools;
Polymerase chain reaction and mass spectrometry;
Nanotechnology and industrial biopolymers;
Transgenic organisms;
Prions, Alzheimer's disease, and neural regeneration;
Inflammation and arthritis;
Therapeutic methodologies and formulations;
Food and beverage formulations;
Restriction endonuclease reactions. Background and Credentials: Mr. Gass received his J.D. from University of California, Berkeley, Boalt Hall School of Law. He attended the University of Michigan as an undergraduate, and graduated with Highest Honors and Highest Distinction with a B.S. in Cell and Molecular Biology. Prior to attending law school, he worked for two years at the University of Michigan as a researcher studying plant mitochondrial genetics. |